JOHN ADDINGTON: Open Payments
NPI 1306942784 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 37 payments from 17 companies in 2025. Trend: 2023 $2,440 · 2024 $2,400 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $164 |
| UROGEN PHARMA, INC. | 4 | $144 |
| Olympus America Inc. | 3 | $135 |
| Merck Sharp & Dohme LLC | 4 | $111 |
| Boston Scientific Corporation | 1 | $99 |
| Janssen Biotech, Inc. | 3 | $65 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $49 |
| COLOPLAST CORP | 2 | $48 |
| BIOPROTECT MEDICAL, INC. | 1 | $44 |
| Calyxo, Inc. | 1 | $26 |
Products named: JELMYTO, iTIND System, GEMTESA, KEYTRUDA, Axonics, ERLEADA, Personal Catheter Intermittent Catheter, BIOPROTECT BALLOON IMPLANT SYSTEM.
Industry payments across MI — which companies pay providers there.
